CUBE vs OCUL · P/E 25, rev $1.07B vs rev $63.7M
CubeSmart (CUBE) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported OCUL revenue for 2024-12-31 was $63.7M. Net income was -$193.5M. Revenue was up 9.0% from 2023-12-31 to 2024-12-31. OCUL currently screens at market cap $1.76B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the CUBE and OCUL stock pages for the full models.
Not investment advice.